Loading clinical trials...
Loading clinical trials...
A Randomized, Parallel, Open-label With Blinded Assessment Study Comparing Hemodynamic Profiles Between Remimazolam- and Propofol-based Total Intravenous Anesthesia in Patients Undergoing Robot-assisted Gynecologic Surgery
This single-center study at CHA Ilsan Medical Center compares intraoperative hemodynamics between remimazolam- and propofol-based total intravenous anesthesia (TIVA) in patients undergoing robot-assisted gynecologic surgery requiring pneumoperitoneum and steep Trendelenburg positioning.
This study aims to compare intraoperative hemodynamic characteristics between remimazolam- and propofol-based total intravenous anesthesia (TIVA) in patients undergoing robot-assisted gynecologic surgery. Continuous invasive blood pressurewill be analyzed to evaluate time-weighted average (TWA) and area-under-the-curve (AUC) differences between groups. The study is designed as a randomized, parallel, open-label with blinded assessment trial.
Age
0 - 65 years
Sex
FEMALE
Healthy Volunteers
No
CHA Ilsan Medical Center
Goyang-si, Gyeonggi-do, South Korea
CHA Ilsan Medical Center
Goyang-si, South Korea
Start Date
January 2, 2026
Primary Completion Date
March 31, 2027
Completion Date
September 30, 2027
Last Updated
November 26, 2025
58
ESTIMATED participants
Remimazolam
DRUG
Propofol
DRUG
Joohyun Lee Assistant Professor, Dept. of Anesthesiology and Pain Medicine, MD
CONTACT
+82-31-782-8415hightothesky1004@gmail.comLead Sponsor
Ilsan Cha hospital
NCT06237101
NCT05526534
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions